Selective accumulation of PpIX and photodynamic effect after aminolevulinic acid treatment of human adenomyosis xenografts in nude mice
other
OA: bronze
public-domain-us
AI-generated summary
Aminolevulinic acid photodynamic therapy led to peak protoporphyrin IX fluorescence at 3 hours and reduced epithelial and stromal cell numbers in human adenomyosis xenografts grown in nude mice.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To evaluate the effect of photodynamic therapy with aminolevulinic acid (ALA) on human adenomyosis xenografts in a mouse model.
DESIGN: Human adenomyosis tissues were implanted SC into nude mice. We measured 5-aminolevulinic acid pharmacokinetics in these mice by analyzing tissue sections 1 to 6 hours after intraperitoneal administration. Twenty-four hours after photodynamic therapy, we evaluated tissue morphologic features.
SETTING: Department of obstetrics and gynecology at a university hospital in Japan.
PATIENT(S): Immunodeficient mice. Tissue grafts were taken from women with adenomyosis attending a university hospital.
INTERVENTION(S): Photodynamic treatment.
MAIN OUTCOME MEASURE(S): Peak fluorescence after intraperitoneal ALA administration and tissue histological changes 24 hours after photodynamic therapy.
RESULT(S): Peak fluorescence was observed 3 hours after intraperitoneal administration. Histological studies revealed decreased numbers of epithelial and stromal cells in adenomyosis models after therapy.
CONCLUSION(S): Photodynamic therapy with ALA caused extensive cell death in human adenomyosis tissues implanted into nude mice. Photodynamic treatment using ALA is a potential treatment for patients with adenomyosis uteri.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-06-20T06:14:18.781669+00:00
- pubmed
- last seen: 2026-05-13T22:14:36.758325+00:00
- unpaywall
- last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine